No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Adjuvant Dabrafenib plus Trametinib Improves Outcomes in Stage III Melanoma

byAstrid BradshawandAlisha Yi

July 3, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

Artificial intelligence matches dermatologists in melanoma diagnosis

2MM: AI Roundup –Dermatology accuracy, faster drug discovery, heart disease detection, and global medical training [September 11th,  2025]

#VisualAbstract: Ridinilazole reduces recurrent Clostridioides difficile infection and preserves gut microbi-ome diversity versus vancomycin

RelatedReports

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

AI Roundup

Artificial intelligence matches dermatologists in melanoma diagnosis

September 15, 2025

AI Roundup

2MM: AI Roundup –Dermatology accuracy, faster drug discovery, heart disease detection, and global medical training [September 11th,  2025]

September 25, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

August 28, 2025

$Bisphosphonate use and risk of atypical femur fractures$

Comparison of hip fracture risk assessment tools for elderly patients

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Merck's Capvaxive Seeks to Become the Primary Shot for Pneumococcal Disease Prevention

#VisualAbstract: Early Weight-Bearing Improves Outcomes in Surgically Treated Ankle Fractures Compared to Delayed Weight-Bearing

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result